533 related articles for article (PubMed ID: 21340093)
1. Apoptotic cell signaling in cancer progression and therapy.
Plati J; Bucur O; Khosravi-Far R
Integr Biol (Camb); 2011 Apr; 3(4):279-96. PubMed ID: 21340093
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies.
Pistritto G; Trisciuoglio D; Ceci C; Garufi A; D'Orazi G
Aging (Albany NY); 2016 Apr; 8(4):603-19. PubMed ID: 27019364
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and molecular targeting therapy in cancer.
Hassan M; Watari H; AbuAlmaaty A; Ohba Y; Sakuragi N
Biomed Res Int; 2014; 2014():150845. PubMed ID: 25013758
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of apoptosis and roles in cancer development and treatment.
Goldar S; Khaniani MS; Derakhshan SM; Baradaran B
Asian Pac J Cancer Prev; 2015; 16(6):2129-44. PubMed ID: 25824729
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.
Plati J; Bucur O; Khosravi-Far R
J Cell Biochem; 2008 Jul; 104(4):1124-49. PubMed ID: 18459149
[TBL] [Abstract][Full Text] [Related]
6. Attacking cancer's Achilles heel: antagonism of anti-apoptotic BCL-2 family members.
Opferman JT
FEBS J; 2016 Jul; 283(14):2661-75. PubMed ID: 26293580
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.
Hassanzadeh A; Farshdousti Hagh M; Alivand MR; Akbari AAM; Shams Asenjan K; Saraei R; Solali S
J Cell Physiol; 2018 Oct; 233(10):6470-6485. PubMed ID: 29741767
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic pathways in tumor progression and therapy.
Melet A; Song K; Bucur O; Jagani Z; Grassian AR; Khosravi-Far R
Adv Exp Med Biol; 2008; 615():47-79. PubMed ID: 18437891
[TBL] [Abstract][Full Text] [Related]
9. Does "death receptor" signaling play a role in tumorigenesis and cancer therapy?
Villunger A; Strasser A
Oncol Res; 1998; 10(11-12):541-50. PubMed ID: 10367935
[TBL] [Abstract][Full Text] [Related]
10. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
11. Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics.
Jan R; Chaudhry GE
Adv Pharm Bull; 2019 Jun; 9(2):205-218. PubMed ID: 31380246
[TBL] [Abstract][Full Text] [Related]
12. Inhibitor of apoptosis proteins as targets for anticancer therapy.
Fulda S
Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
[TBL] [Abstract][Full Text] [Related]
13. Regulation of apoptosis proteins in cancer cells by ubiquitin.
Zhang HG; Wang J; Yang X; Hsu HC; Mountz JD
Oncogene; 2004 Mar; 23(11):2009-15. PubMed ID: 15021888
[TBL] [Abstract][Full Text] [Related]
14. Role of genomics-based strategies in overcoming chemotherapeutic resistance.
Kumar MV; Shirley R; Ma Y; Lewis RW
Curr Pharm Biotechnol; 2004 Oct; 5(5):471-80. PubMed ID: 15544495
[TBL] [Abstract][Full Text] [Related]
15. Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer.
Bagnoli M; Canevari S; Mezzanzanica D
Int J Biochem Cell Biol; 2010 Feb; 42(2):210-3. PubMed ID: 19932761
[TBL] [Abstract][Full Text] [Related]
16. FLIP as a therapeutic target in cancer.
Humphreys L; Espona-Fiedler M; Longley DB
FEBS J; 2018 Nov; 285(22):4104-4123. PubMed ID: 29806737
[TBL] [Abstract][Full Text] [Related]
17. Overview of cell death signaling pathways.
Jin Z; El-Deiry WS
Cancer Biol Ther; 2005 Feb; 4(2):139-63. PubMed ID: 15725726
[TBL] [Abstract][Full Text] [Related]
18. The caspase-8 modulator c-FLIP.
Kataoka T
Crit Rev Immunol; 2005; 25(1):31-58. PubMed ID: 15833082
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.
Yang L; Cao Z; Yan H; Wood WC
Cancer Res; 2003 Oct; 63(20):6815-24. PubMed ID: 14583479
[TBL] [Abstract][Full Text] [Related]
20. Targeting IAP (inhibitor of apoptosis) proteins for therapeutic intervention in tumors.
Vucic D
Curr Cancer Drug Targets; 2008 Mar; 8(2):110-7. PubMed ID: 18336193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
